A patient with hepatic cirrhosis is started on a drug with high hepatic extraction ratio. What is the expected change in bioavailability?
-
A
Increased bioavailability due to reduced first-pass metabolism
-
B
Decreased bioavailability due to impaired absorption
-
C
No change because hepatic extraction is unaffected
-
D
Decreased bioavailability due to increased protein binding